{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:36:47Z","timestamp":1790685407479,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.canlet.2013.02.001","type":"journal-article","created":{"date-parts":[[2013,2,9]],"date-time":"2013-02-09T06:18:31Z","timestamp":1360390711000},"page":"136-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Androgens regulate TRAIL-induced cell death in prostate cancer cells via multiple mechanisms"],"prefix":"10.1016","volume":"335","author":[{"given":"Diping","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald J.","family":"Tindall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2013.02.001_b0005","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/(SICI)1097-0045(19970901)32:4<284::AID-PROS9>3.0.CO;2-J","article-title":"Target to apoptosis: a hopeful weapon for prostate cancer","volume":"32","author":"Tang","year":"1997","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2013.02.001_b0010","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/pros.20421","article-title":"Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players","volume":"66","author":"Hesry","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2013.02.001_b0015","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/(SICI)1097-0045(199611)29:5<296::AID-PROS4>3.0.CO;2-8","article-title":"TNF-mediated cytotoxicity and resistance in human prostate cancer cell lines","volume":"29","author":"Nakajima","year":"1996","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2013.02.001_b0020","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00109-007-0194-1","article-title":"The promise of TRAIL \u2013 potential and risks of a novel anticancer therapy","volume":"85","author":"Koschny","year":"2007","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.canlet.2013.02.001_b0025","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ctrv.2008.11.006","article-title":"TRAIL receptor signalling and modulation: are we on the right TRAIL?","volume":"35","author":"Mahalingam","year":"2009","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.canlet.2013.02.001_b0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.drup.2008.02.001","article-title":"TRAIL receptor-targeted therapeutics: resistance mechanisms and strategies to avoid them","volume":"11","author":"Thorburn","year":"2008","journal-title":"Drug Resist. Update"},{"key":"10.1016\/j.canlet.2013.02.001_b0035","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2741\/1903","article-title":"APO2 ligand\/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy","volume":"11","author":"Bucur","year":"2006","journal-title":"Front Biosci."},{"key":"10.1016\/j.canlet.2013.02.001_b0040","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/cdd.2010.135","article-title":"BID is cleaved by caspase-8 within a native complex on the mitochondrial membrane","volume":"18","author":"Schug","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2013.02.001_b0045","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s10495-005-2490-y","article-title":"Sensitization of prostate carcinoma cells to Apo2L\/TRAIL by a Bcl-2 family protein inhibitor","volume":"10","author":"Ray","year":"2005","journal-title":"Apoptosis"},{"key":"10.1016\/j.canlet.2013.02.001_b0050","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1038\/sj.onc.1204504","article-title":"TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2","volume":"20","author":"Munshi","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2013.02.001_b0055","doi-asserted-by":"crossref","first-page":"10767","DOI":"10.1074\/jbc.M005196200","article-title":"Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis","volume":"276","author":"Nesterov","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2013.02.001_b0060","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1038\/sj.onc.1204736","article-title":"Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer","volume":"20","author":"Chen","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2013.02.001_b0065","doi-asserted-by":"crossref","first-page":"38361","DOI":"10.1074\/jbc.M103321200","article-title":"Pro-survival function of Akt\/protein kinase B in prostate cancer cells. Relationship with TRAIL resistance","volume":"276","author":"Thakkar","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2013.02.001_b0070","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/107999001300177501","article-title":"Differential effects of phosphatidylinositol-3\/Akt-kinase inhibition on apoptotic sensitization to cytokines in LNCaP and PCc-3 prostate cancer cells","volume":"21","author":"Beresford","year":"2001","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.canlet.2013.02.001_b0075","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/ijc.24374","article-title":"The Akt inhibitor triciribine sensitizes prostate carcinoma cells to TRAIL-induced apoptosis","volume":"125","author":"Dieterle","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2013.02.001_b0080","first-page":"120","article-title":"Wortmannin elevates tumor necrosis factor-related apoptosis-inducing ligand sensitivity in LNCaP cells through down-regulation of IAP-2 protein","volume":"27","author":"Seol","year":"2005","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.canlet.2013.02.001_b0085","doi-asserted-by":"crossref","first-page":"631","DOI":"10.4161\/cbt.311","article-title":"TRAIL\u2013DISC formation is androgen-dependent in the human prostatic carcinoma cell line LNCaP","volume":"1","author":"Rokhlin","year":"2002","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.canlet.2013.02.001_b0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1475-2867-11-42","article-title":"Down-regulation of DcR2 sensitizes androgen-dependent prostate cancer LNCaP cells to TRAIL-induced apoptosis","volume":"11","author":"Vindrieux","year":"2011","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.canlet.2013.02.001_b0095","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.1038\/sj.onc.1208833","article-title":"Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP","volume":"24","author":"Rokhlin","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2013.02.001_b0100","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/pros.20844","article-title":"Induction of FLIP expression by androgens protects prostate cancer cells from TRAIL-mediated apoptosis","volume":"68","author":"Raclaw","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2013.02.001_b0105","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1038\/onc.2008.80","article-title":"FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells","volume":"27","author":"Cornforth","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2013.02.001_b0110","doi-asserted-by":"crossref","first-page":"27882","DOI":"10.1074\/jbc.M605002200","article-title":"Ligand-independent androgen receptor activity is activation function-2-independent and resistant to antiandrogens in androgen refractory prostate cancer cells","volume":"281","author":"Dehm","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2013.02.001_b0115","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1158\/0008-5472.CAN-08-0594","article-title":"Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance","volume":"68","author":"Dehm","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2013.02.001_b0120","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1158\/0008-5472.CAN-09-1903","article-title":"Reduced tumor necrosis factor receptor-associated death domain expression is associated with prostate cancer progression","volume":"69","author":"Wang","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2013.02.001_b0125","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/pros.20584","article-title":"Increased resistance to trail-induced apoptosis in prostate cancer cells selected in the presence of bicalutamide","volume":"67","author":"Mitterberger","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2013.02.001_b0130","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1158\/1078-0432.CCR-07-1133","article-title":"Low-dose 12-O-tetradecanoylphorbol-13-acetate enhances tumor necrosis factor related apoptosis-inducing ligand induced apoptosis in prostate cancer cells","volume":"13","author":"Zhang","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2013.02.001_b0135","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1074\/jbc.M410660200","article-title":"Receptor-selective mutants of apoptosis-inducing ligand 2\/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling","volume":"280","author":"Kelley","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2013.02.001_b0140","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.febslet.2011.05.034","article-title":"TRADD is critical for resistance to TRAIL-induced cell death through NF-kappaB activation","volume":"585","author":"Kim","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2013.02.001_b0145","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1128\/MCB.26.9.3505-3513.2006","article-title":"Competitive control of independent programs of tumor necrosis factor receptor-induced cell death by TRADD and RIP1","volume":"26","author":"Zheng","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2013.02.001_b0150","first-page":"5611","article-title":"Androgen blocks apoptosis of hormone-dependent prostate cancer cells","volume":"61","author":"Kimura","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2013.02.001_b0155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1126\/science.276.5309.111","article-title":"The receptor for the cytotoxic ligand TRAIL","volume":"276","author":"Pan","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.canlet.2013.02.001_b0160","first-page":"111","article-title":"Reduced response of prostate cancer cells to TRAIL is modulated by NFkappaB-mediated inhibition of caspases and Bid activation","volume":"21","author":"Eid","year":"2002","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2013.02.001_b0165","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1158\/1535-7163.803.3.7","article-title":"Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand\/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation","volume":"3","author":"Deeb","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2013.02.001_b0170","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0092-8674(95)90070-5","article-title":"The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation","volume":"81","author":"Hsu","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2013.02.001_b0175","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1038\/sj.onc.1204393","article-title":"Transcriptional activation of TRADD mediates p53-independent radiation-induced apoptosis of glioma cells","volume":"20","author":"Yount","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2013.02.001_b0180","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1096\/fj.10-170480","article-title":"The role of TRADD in TRAIL-induced apoptosis and signaling","volume":"25","author":"Cao","year":"2011","journal-title":"Faseb J."},{"key":"10.1016\/j.canlet.2013.02.001_b0185","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1210\/me.2004-0445","article-title":"The androgen receptor directly targets the cellular Fas\/FasL-associated death domain protein-like inhibitory protein gene to promote the androgen-independent growth of prostate cancer cells","volume":"19","author":"Gao","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.canlet.2013.02.001_b0190","doi-asserted-by":"crossref","first-page":"7494","DOI":"10.1038\/sj.onc.1208049","article-title":"Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms","volume":"23","author":"Chakravarti","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2013.02.001_b0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc2293","article-title":"Survivin, cancer networks and pathway-directed drug discovery","volume":"8","author":"Altieri","year":"2008","journal-title":"Nat. Rev. Cancer"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383513001122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383513001122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T10:28:44Z","timestamp":1688034524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383513001122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0304383513001122"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2013.02.001","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Androgens regulate TRAIL-induced cell death in prostate cancer cells via multiple mechanisms","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2013.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}